These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. An intervention study for the prevention of vasovagal reactions and evaluating donors' experience: Analysis of donors' return for subsequent donation. Wiersum-Osselton J; Prinsze F; van den Brekel E; van Dongen A; Hermans F; Bokhorst A; der Kreek TM Vox Sang; 2022 Mar; 117(3):313-320. PubMed ID: 34396539 [TBL] [Abstract][Full Text] [Related]
43. Does using applied muscle tension at strategic time points during donation reduce phlebotomist- and donor-reported vasovagal reaction rates? A three-armed randomized controlled trial. Thijsen A; Gemelli CN; Davison TE; O'Donovan J; Bell B; Masser B Transfusion; 2018 Oct; 58(10):2352-2359. PubMed ID: 30222861 [TBL] [Abstract][Full Text] [Related]
44. Improving safety for young blood donors. Eder AF Transfus Med Rev; 2012 Jan; 26(1):14-26. PubMed ID: 21872427 [TBL] [Abstract][Full Text] [Related]
46. Rates and reasons for blood donor deferral, Shiraz, Iran. A retrospective study. Kasraian L; Negarestani N Sao Paulo Med J; 2015 Feb; 133(1):36-42. PubMed ID: 25166463 [TBL] [Abstract][Full Text] [Related]
47. Increasing regular donors through a psychological approach which reduces the onset of vasovagal reactions. Pagliariccio A; Marinozzi M Transfus Apher Sci; 2012 Dec; 47(3):301-4. PubMed ID: 22727917 [TBL] [Abstract][Full Text] [Related]
48. Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria. Okoroiwu HU; Asemota EA BMC Health Serv Res; 2019 Jul; 19(1):510. PubMed ID: 31331326 [TBL] [Abstract][Full Text] [Related]
49. Extracorporeal blood volume of donors during automated intermittent-flow plasmapheresis and its relevance to the prevention of circulatory reactions. Karger R; Slonka J; Junck H; Kretschmer V Transfusion; 2003 Aug; 43(8):1096-106. PubMed ID: 12869116 [TBL] [Abstract][Full Text] [Related]
51. Donor complication rates in whole blood, plasma and platelet donors: Age versus experience. Paalvast Y; Díaz Padilla N; Bruijns S; Wiersum-Osselton J; Molenaar T Transfusion; 2024 May; 64(5):854-865. PubMed ID: 38385649 [TBL] [Abstract][Full Text] [Related]
52. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006. Zou S; Musavi F; Notari EP; Rios JA; Trouern-Trend J; Fang CT Transfusion; 2008 Dec; 48(12):2531-9. PubMed ID: 18717777 [TBL] [Abstract][Full Text] [Related]
53. Vasovagal reactions in blood donors: risks, prevention and management. Thijsen A; Masser B Transfus Med; 2019 Apr; 29 Suppl 1():13-22. PubMed ID: 29148259 [TBL] [Abstract][Full Text] [Related]
54. A randomized controlled trial of a tablet-based intervention to address predonation fears among high school donors. France CR; France JL; Kowalsky JM; Conatser R; Duffy L; Barnofsky N; Kessler D; Shaz B Transfusion; 2020 Jul; 60(7):1450-1453. PubMed ID: 32286685 [TBL] [Abstract][Full Text] [Related]
55. Vasovagal reactions in blood donors during or immediately after blood donation. Zervou EK; Ziciadis K; Karabini F; Xanthi E; Chrisostomou E; Tzolou A Transfus Med; 2005 Oct; 15(5):389-94. PubMed ID: 16202053 [TBL] [Abstract][Full Text] [Related]
56. Frequency and risk factors for donor reactions in an anonymous blood donor survey. Goldman M; Osmond L; Yi QL; Cameron-Choi K; O'Brien SF Transfusion; 2013 Sep; 53(9):1979-84. PubMed ID: 23228195 [TBL] [Abstract][Full Text] [Related]
57. Incidence and severity of adverse events among platelet donors: A three-year retrospective study. Almutairi H; Salam M; Batarfi K; Alharbi D; Wani F; Almutairi A; Al-Shammari B; Al-Surimi K Medicine (Baltimore); 2020 Dec; 99(52):e23648. PubMed ID: 33350744 [TBL] [Abstract][Full Text] [Related]